prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 266
2017
-
BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.
Year: 2017, type: Conference abstract
-
Buněčná biologie folikulárního lymfomu
Folikulární lymfom, edition: První vyd., year: 2017, number of pages: 21 s.
-
Comparative analysis of miRNA profiles in human patients with epilepsy and animal model
Year: 2017, type: Conference abstract
-
Comparative analysis of miRNA profiles in human patients with epilepsy and animal models
Year: 2017, type: Conference abstract
-
Differential expression of microRNAs in transformation of follicular lymphoma to diffuse large B cell lymphoma
Year: 2017, type: Conference abstract
-
Dopad rekurentních mutací na dobu do progrese po terapiích zahrnujících rituximab v 1. linii u pacientů s CLL.
Year: 2017, type: Conference abstract
-
Down-regulation of miR-150 and up-regulation of its target FOXP1 is associated with transformation of follicular lymphoma.
Year: 2017, type: Conference abstract
-
Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients
American Journal of Hematology, year: 2017, volume: 92, edition: 10, DOI
-
Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens.
Year: 2017, type: Conference abstract
-
MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus
Epilepsia, year: 2017, volume: 58, edition: 10, DOI